Posts with tag: programming
Oceaneering International Inc. reports Q4 net income of $56.1 million, or 55 cents per share, and revenue of $713.5 million. For the year, the company reported profit of $147.5 million, or $1.44 per share, and revenue of $2.66 billion.
Published on: February 19, 2025, 11:07 PM UTC
Struggling Against Inflation, Rogers Corp Posts a Fourth-Quarter Loss
Published on: February 19, 2025, 11:06 PM UTC
New Gold Inc. reports fourth-quarter earnings of $55.1 million, topping Wall Street expectations, with revenue of $262.2 million.
Published on: February 19, 2025, 11:05 PM UTC
Fed Vice Chair Jefferson says the Federal Reserve has time to consider its next monetary policy move given the robust economy and still-elevated inflation.
Published on: February 19, 2025, 11:05 PM UTC
UK Prime Minister Keir Starmer reiterates support for Ukrainian President Volodymyr Zelenskiy, despite criticism from US President Donald Trump.
Published on: February 19, 2025, 11:04 PM UTC
A report of coming layoffs at the Federal Housing Administration is casting fresh doubts about the future of an office responsible for insuring millions of mortgages across the country.
Published on: February 19, 2025, 11:03 PM UTC
Wall Street rose, with the S&P 500 setting a new record high, as investors weighed the latest tariff threats from President Trump and news of a potential deal between Broadcom and Intel. Traders also digested the Federal Reserve's meeting minutes, which revealed that most central bank officials supported holding policy at restrictive levels amid concerns about persistent inflation.
Published on: February 19, 2025, 11:02 PM UTC
Carvana beats on revenue and profit in Q4, but shares fall after hours as company cites 'significant growth' in 2025.
Published on: February 19, 2025, 11:02 PM UTC
BioMarin Pharmaceutical (NASDAQ: BMRN) reported strong Q4 results, beating analyst estimates for both revenue and EPS. The company's full-year revenue guidance came in above expectations, and its adjusted EPS guidance for the upcoming year is also above estimates. BioMarin's key takeaways for Q4 include revenue growth of 15.6% year-over-year, adjusted EPS of $0.92 vs. estimates of $0.74, revenue guidance of $3.15 billion, and adjusted EPS guidance of $4.30.
Published on: February 19, 2025, 10:11 PM UTC
Exact Sciences Corporation (EXAS) reported better-than-expected Q4 CY2024 revenue of $713.4 million, a 10.3% year-on-year increase. Despite a non-GAAP loss per share of $0.06, the company's adjusted EPS and EBITDA outperformed analysts' estimates. Revenue guidance for 2025 is in line with expectations, while EBITDA guidance falls short. Consider reading our full research report for a comprehensive analysis of Exact Sciences' financial performance and investment potential.
Published on: February 19, 2025, 10:10 PM UTC